Literature DB >> 6234387

Nasal absorption of nafarelin acetate, the decapeptide [D-Nal(2)6)]LHRH, in rhesus monkeys. I.

S T Anik, G McRae, C Nerenberg, A Worden, J Foreman, J Y Hwang, S Kushinsky, R E Jones, B Vickery.   

Abstract

Nafarelin acetate, [D-Nal(2)6]LHRH, a highly potent superagonist of luteinizing hormone-releasing hormone, was given intranasally to six female rhesus monkeys. Absorption was rapid and very reproducible, with peak levels occurring at 15-30 min and a bioavailability of approximately 2% relative to a subcutaneous dose. The nasal dose response was highly nonlinear. The nonlinearity was apparently associated with the absorption phase, since elimination profiles at all doses were similar.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234387     DOI: 10.1002/jps.2600730523

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

2.  The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.

Authors:  M A Hussain; A B Shenvi; S M Rowe; E Shefter
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

Review 3.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

4.  The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.

Authors:  P A Baldwin; C K Klingbeil; C J Grimm; J P Longenecker
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

5.  Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. I. Effects of ionic strength, adjuvant composition, and lipid structure on the nasal absorption of [D-Arg2]kyotorphin.

Authors:  P Tengamnuay; A K Mitra
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

6.  Noninvasive routes of proteins and peptides drug delivery.

Authors:  P K Sharma; Sumedha Bansal; Arunabha Banik
Journal:  Indian J Pharm Sci       Date:  2011-07       Impact factor: 0.975

7.  Preventive Activity against Influenza (H1N1) Virus by Intranasally Delivered RNA-Hydrolyzing Antibody in Respiratory Epithelial Cells of Mice.

Authors:  Seungchan Cho; Ha-Na Youn; Phuong Mai Hoang; Sungrae Cho; Kee-Eun Kim; Eui-Joon Kil; Gunsup Lee; Mun-Ju Cho; Juhyun Hong; Sung-June Byun; Chang-Seon Song; Sukchan Lee
Journal:  Viruses       Date:  2015-09-21       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.